OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

December 1, 2025

Conditions
AML, Adult
Trial Locations (21)

45000

NOT_YET_RECRUITING

Orléans CHU, Orléans

59385

RECRUITING

DUNKERQUE-Hôpital Alexandra Lepève, Dunkirk

68100

RECRUITING

Mulhouse Chu, Mulhouse

Unknown

NOT_YET_RECRUITING

Amiens CHU, Amiens

NOT_YET_RECRUITING

Angers CHU, Angers

NOT_YET_RECRUITING

Bayonne CH, Bayonne

NOT_YET_RECRUITING

Besançon CHU, Besançon

RECRUITING

CHU Estaing, Clermont-Ferrand

RECRUITING

Créteil CHU HENRI MONDOR, Créteil

NOT_YET_RECRUITING

Grenoble CHU, Grenoble

NOT_YET_RECRUITING

Le Mans CH, Le Mans

NOT_YET_RECRUITING

Lyon sud CHU, Lyon

NOT_YET_RECRUITING

Marseille IPC, Marseille

RECRUITING

Meaux CH de l'Est francilien, Meaux

NOT_YET_RECRUITING

Montpellier - Chu Saint Eloi, Montpellier

RECRUITING

Nantes CHU, Nantes

NOT_YET_RECRUITING

Nice CHU, Nice

NOT_YET_RECRUITING

Paris Saint Louis, Paris

NOT_YET_RECRUITING

Bordeaux CHU, Pessac

NOT_YET_RECRUITING

ICANS - Institut de cancérologie de strasbourg europe, Strasbourg

NOT_YET_RECRUITING

Toulouse - IUCT Oncopole - Service d'Hématologie, Toulouse

All Listed Sponsors
collaborator

Acute Leukemia French Association

OTHER

lead

French Innovative Leukemia Organisation

OTHER